Current real-world treatment patterns and outcomes in patients with relapsed/refractory multiple myeloma.

被引：0
|
作者：
Willson, Jenny
Bruno, Amanda
Opalinska, Joanna
Nelson, Jeanenne Joy
Lunacsek, Orsolya
Stafkey-Mailey, Dana
Willey, Joanne P.
机构：
[1] GSK, London, England
[2] GlaxoSmithKline, Collegeville, PA USA
[3] GlaxoSmithKline, Res Triangle Pk, NC USA
[4] Xcenda, Palm Harbor, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e20038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20038
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Real-world treatment patterns and clinical outcomes in patients with triple-class exposed relapsed or refractory multiple myeloma in United States clinical practice
    Chari, Ajai
    Nair, Sandhya
    Lin, Xiwu
    Marshall, Alexander
    Slavcev, Mary
    Kumar, Shaji
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S165 - S166
  • [32] KarMMa-RW: A study of real-world treatment patterns in heavily pretreated patients with Relapsed and Refractory Multiple Myeloma (RRMM) and comparison of outcomes to KarMMa
    Goldschmidt, H.
    Jagannath, S.
    Lin, Y.
    Reece, D.
    Nooka, A.
    Senin, A.
    Rodriguez Otero, P.
    Powles, R.
    Matsue, K.
    Shah, N.
    Anderson, L., Jr.
    Wilson, K.
    Le, H., V
    Agarwal, A.
    Siegel, D. S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 93 - 93
  • [33] Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients
    Lovas, Szilvia
    Varga, Gergely
    Farkas, Peter
    Masszi, Tamas
    Wohner, Nikolett
    Bereczki, Agnes
    Adamkovich, Nora
    Borbenyi, Zita
    Szomor, Arpad
    Alizadeh, Hussain
    Szaleczky, Erika
    Wolf, Krisztina
    Schneider, Tamas
    Plander, Mark
    Szendrei, Tamas
    Csacsovszki, Otto
    Csukly, Zoltan
    Rajnics, Peter
    Egyed, Miklos
    Nagy, Zsolt
    Rejto, Laszlo
    Illes, Arpad
    Mikala, Gabor
    Varoczy, Laszlo
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (05) : 559 - 565
  • [34] Real World Treatment of Patients with Relapsed/Refractory Myeloma
    Dimopoulos, Meletios A.
    Ntanasis-Stathopoulos, Ioannis
    Terpos, Evangelos
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S24 - S27
  • [35] Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients
    Szilvia Lovas
    Gergely Varga
    Péter Farkas
    Tamás Masszi
    Nikolett Wohner
    Ágnes Bereczki
    Nóra Adamkovich
    Zita Borbényi
    Árpád Szomor
    Hussain Alizadeh
    Erika Szaleczky
    Krisztina Wolf
    Tamás Schneider
    Márk Plander
    Tamás Szendrei
    Ottó Csacsovszki
    Zoltán Csukly
    Péter Rajnics
    Miklós Egyed
    Zsolt Nagy
    László Rejtő
    Árpád Illés
    Gábor Mikala
    László Váróczy
    [J]. International Journal of Hematology, 2019, 110 : 559 - 565
  • [36] Real-world analysis of belantamab mafodotin (belamaf): Care patterns in relapsed/refractory multiple myeloma
    Patel, Mihir
    Locke, Susan C.
    Falvey, Caroline
    Troy, Jesse D.
    Herring, Kris W.
    Bolgioni-Smith, Amanda
    Doherty, Allison
    Elcock, Cherie Howard
    Iadeluca, Laura L.
    LeBlanc, Thomas William
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Real-World Disparities in Daratumumab Utilization for Patients with Relapsed or Refractory Multiple Myeloma (MM)
    Maignan, Kathleen
    Backenroth, Daniel
    McQuarrie, Neil A.
    Lipitz, Nicole G.
    Williams, Erin R.
    Carson, Kenneth R.
    [J]. BLOOD, 2018, 132
  • [38] Safety and Efficacy of Teclistamab in Patients with Relapsed/ Refractory Multiple Myeloma: A Real-World Experience
    Dima, Danai
    Davis, James A.
    Ahmed, Nausheen
    Jia, Xuefei
    Sannareddy, Aishwarya
    Shaikh, Hira
    Shune, Leyla
    Kaur, Gurbakhash
    Khouri, Jack
    Afrough, Aimaz
    Strouse, Christopher
    Lochner, Jonathan
    Mahmoudjafari, Zahra
    Raza, Shahzad
    Valent, Jason
    Anderson Jr, Larry D.
    Anwer, Faiz
    Abdallah, Al-Ola
    Hashmi, Hamza
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03):
  • [39] Tolerability and safety of real-world use of pomalidomide in patients with relapsed/refractory multiple myeloma
    Usami, Eiseki
    Kimura, Michio
    Takenaka, Shoya
    Iwai, Mina
    Teramachi, Hitomi
    Yoshimura, Tomoaki
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (02) : 293 - 298
  • [40] Teclistamab in Relapsed/Refractory Multiple Myeloma: Real-World Outcomes at a Single Academic Center in the Midwest
    Stepanovic, Adam
    Abonour, Rafat
    Abu Zaid, Mohammad
    Farag, Sherif
    Lee, Kelvin P.
    Suvannasankha, Attaya
    [J]. BLOOD, 2023, 142
12345